Study of Low-Magnitude, High-Frequency Vibration Treatment on Osteoporotic Hip Fracture Healing
NCT ID: NCT01293721
Last Updated: 2012-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
72 participants
INTERVENTIONAL
2011-11-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Low-magnitude, high-frequency vibration (LMHFV) treatment is a biophysical intervention to provide whole-body vibration signals for mechanical stimulation, which has been proven to be good in enhancing bone and muscle performance, as well as blood circulation. Our previous study of LMHFV on femoral fracture in rats showed acceleration of fracture healing, resulted from enhanced callus formation and maturation. Application of LMHFV on osteoporotic fractures could shorten the period of complete callus bridging by 30%. Our clinical trial on normal elderly also demonstrated improved muscle performance with good compliance, which is also a critical factor for fracture healing.
In this study, the investigators therefore hypothesize that LMHFV can enhance hip fracture healing by enhancing fracture impaction, maintaining bone mineral density, enhancing muscle recovery, thus improving implant mechanical stability and rehabilitation in elderly patients. The hip fracture elderly patient will be recruited and randomized into control or treatment group. They will be assessed on the fracture healing at fixed time point. The findings of this study will provide very useful scientific data to support the application of LMHFV for hip fracture patients.The ultimate goal is to enhance the fracture healing and rehabilitation in elderly patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients
NCT04063891
Effect of Low-Magnitude, High Frequency Vibration Treatment on Femoral Shaft Fracture Healing
NCT01386749
Use of Mobile App to Enhance Geriatric Hip Fracture Rehabilitation
NCT04053348
Vibration in Boys With a History of Fracture
NCT04241432
Ultrasound Assessment of Gastric Contents in Fasted Elderly Patients With Hip Fracture
NCT03242733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
No interventions assigned to this group
Treatment
Receive vibration therapy
Low-magnitude high - frequency vibration treatment
stand on a vibration platform at 35Hz, 0.3g, 20mins/day and 7 days/week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-magnitude high - frequency vibration treatment
stand on a vibration platform at 35Hz, 0.3g, 20mins/day and 7 days/week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient fixed with dynamic hip screw
Exclusion Criteria
* having of hormone replacement therapy or drug treatment known to affect bone metabolism or cause spontaneous bone loss
* having hypo- or hyperparathyroidism and hypo-, hyperthyroidism, renal or liver disease
* cannot tolerate or complication occurs during study
* patients whose fracture is due to underlying disease, secondary to malignancy
65 Years
85 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kwok-Sui Leung
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kwok Sui Leung, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Orthopaedics and Traumatology, The Chineses University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-KSWH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.